chr6-29588553-C-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_007160.4(OR2H2):āc.609C>Gā(p.Phe203Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000195 in 974,110 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_007160.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
OR2H2 | NM_007160.4 | c.609C>G | p.Phe203Leu | missense_variant | 2/2 | ENST00000641840.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
OR2H2 | ENST00000641840.1 | c.609C>G | p.Phe203Leu | missense_variant | 2/2 | NM_007160.4 | P1 | ||
OR2H2 | ENST00000383640.4 | c.609C>G | p.Phe203Leu | missense_variant | 1/1 | P1 | |||
GABBR1 | ENST00000355973.7 | c.*2+14988G>C | intron_variant | 2 |
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152224Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00000810 AC: 2AN: 246798Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 134418
GnomAD4 exome AF: 0.0000195 AC: 16AN: 821886Hom.: 0 Cov.: 11 AF XY: 0.0000207 AC XY: 9AN XY: 434216
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152224Hom.: 0 Cov.: 32 AF XY: 0.0000134 AC XY: 1AN XY: 74368
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 28, 2022 | The c.609C>G (p.F203L) alteration is located in exon 1 (coding exon 1) of the OR2H2 gene. This alteration results from a C to G substitution at nucleotide position 609, causing the phenylalanine (F) at amino acid position 203 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at